Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
New York, USA, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Global Point-of-Care Molecular Diagnostics Market is Expected to Expand at a Healthy Growth Rate of ~10% by 2034 | DelveInsight The point-of-care...
-
New York, USA, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Esophageal Cancer Market to Accelerate at a CAGR of 6% During the Forecast Period (2026–2036), Driven by the Advancements in Targeted and...
-
New York, USA, July 30, 2026 (GLOBE NEWSWIRE) -- Peripheral Artery Disease Clinical Trial Pipeline Expands as 17+ Companies Race to Redefine Peripheral Artery Disease Treatment Landscape |...
-
New York, USA, July 29, 2026 (GLOBE NEWSWIRE) -- Global Radiopharmaceutical CDMO Market to Accelerate Substantially at a CAGR of ~10% by 2034 | DelveInsight The radiopharmaceutical CDMO market is...
-
New York, USA, July 28, 2026 (GLOBE NEWSWIRE) -- Amylin Analogs and Combination Therapies Clinical Trial Landscape Expands as 15+ Leading Companies Accelerate Drug Development | DelveInsight The...
-
New York, USA, July 27, 2026 (GLOBE NEWSWIRE) -- Necrotizing Enterocolitis Market to Register Stunning Growth at a CAGR of 26% During the Forecast Period (2026–2036) | DelveInsight The necrotizing...
-
New York, USA, July 23, 2026 (GLOBE NEWSWIRE) -- Molecular Glues Clinical Trial Landscape: 80+ Emerging Competitors, Pipeline Dynamics, and Future Opportunities | DelveInsight The molecular glues...
-
New York, USA, July 22, 2026 (GLOBE NEWSWIRE) -- Global Robotic Endoscopy Devices Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~10% by 2034 | DelveInsight The robotic endoscopy...
-
New York, USA, July 21, 2026 (GLOBE NEWSWIRE) -- PD-1 and PD-L1 Inhibitors Clinical Trial Pipeline Analysis Demonstrates 180+ Key Companies on the Horizon Expected to Transform the Oncology Space |...
-
New York, USA, July 21, 2026 (GLOBE NEWSWIRE) -- Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of...